DEEP RESEARCH · A-PLUS ASSET
A-Plus Asset: A High-Efficiency GA with a Total Life Care Moat
A review of insurance distribution, cash-flow quality, and subsidiaries based on 3Q 2025 results
0. Bottom line first
The source argues that A-Plus Asset is not merely a large GA. It is reinforcing a corporate, high-efficiency GA model by combining quality metrics such as persistency and mis-selling rates with healthcare, funeral service, and real-estate affiliates.
Official fact: According to the source, cumulative 3Q 2025 operating revenue was KRW 501.7 billion and operating profit was KRW 22.5 billion. The 13-month persistency rates were 92.1% for life insurance and 88.2% for non-life insurance, while the 25-month life insurance persistency rate was 82.8%. Mis-selling rates were 0.02% for life insurance and 0.00% for non-life insurance.
Interpretation: After IFRS17, insurers want long-lasting contracts that do not damage CSM. A-Plus Asset’s strength is therefore not simply selling more, but selling contracts that remain in force.
1. Structural change in the GA industry
As the separation of insurance manufacturing and sales accelerates, GAs have become more influential. At the same time, the 1200% rule, stronger internal-control demands, and consumer-protection regulation require contract quality and cash-flow resilience, not just scale.
2. Insurance sales: profitability built on efficiency
The source gives cumulative 3Q 2025 insurance-product revenue of KRW 206.8 billion from life insurance and KRW 235.2 billion from non-life insurance. This balance can offset weakness in any single product category.
- The number of planners was 7,332 at the end of 3Q 2025, up about 29.7% from 5,654 at the prior year-end.
- Average monthly sales cases rose to 45,958 from 41,370.
- Average monthly initial premiums increased to KRW 4.58 billion from KRW 4.06 billion.
- Order-made products based on more than 3 million customer data points are a key differentiator beyond simple distribution.
3. Subsidiaries: cash flow beyond insurance
NanoEntek
Manufactures and sells in-vitro diagnostic devices and life-science instruments. The source cites cumulative 3Q 2025 revenue of KRW 24.9 billion, about 5% of total revenue.
A-Plus Life
Cumulative 3Q 2025 revenue was KRW 18.2 billion. The prepaid funeral model has float-like cash-flow characteristics.
AAI Healthcare
Combines health-management solutions with insurance sales touchpoints.
A-Plus Mortgage
Described as a stable revenue source in loan brokerage.
4. A-Plus Asset versus volume-led GAs
| Category | A-Plus Asset | Volume-led GA | Investor read |
|---|---|---|---|
| Growth model | High-efficiency, selective organization | Large organization and scale expansion | Balance between profitability and share |
| Moat | BOPLE, customer data, order-made products | Planner count and branch network | Data and product planning are differentiators |
| Switching cost | Insurance + funeral + healthcare bundle | Insurance-product centric | Life-care ecosystem can create lock-in |
| Risk | Regulation, big-tech comparison services, real-estate weakness | Internal-control cost and contract quality | Maintaining quality metrics is key |
5. Risks and outlook
Stronger GA internal-control requirements, scrutiny around the 1200% rule, and higher penalties for mis-selling remain variables. Big-tech insurance comparison services from players such as Kakao and Toss can threaten simpler insurance lines. However, complex products such as whole-life, variable, and integrated health insurance still require face-to-face consulting capability.
Interpretation: The re-rating question is whether A-Plus Asset can be viewed not as a simple insurance distributor, but as a lifestyle finance platform for an aging society. Cash-like assets, dividend appeal, and NanoEntek’s technology potential should be evaluated in that frame.